ProShare Advisors
ACH

ProShare Advisors’s Accendra Health ACH Stock Holding History

ProShare Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,931
Closed -$24.9K – 1989
2026
Q1 		$24.9K Sell
10,931
-2,850
-21% -$6.56K ﹤0.01% 1833
2025
Q4 		$38.6K Buy
13,781
+886
+7% +$3.17K ﹤0.01% 1978
2025
Q3 		$61.9K Sell
12,895
-3,900
-23% -$24.8K ﹤0.01% 1908
2025
Q2 		$153K Sell
16,795
-937
-5% -$6.91K ﹤0.01% 1786
2025
Q1 		$160K Sell
17,732
-4,970
-22% -$52.5K ﹤0.01% 1748
2024
Q4 		$297K Buy
22,702
+6,996
+45% +$93.3K ﹤0.01% 1641
2024
Q3 		$246K Buy
15,706
+4,292
+38% +$65K ﹤0.01% 1593
2024
Q2 		$154K Sell
11,414
-3,607
-24% -$73.9K ﹤0.01% 1586
2024
Q1 		$416K Buy
15,021
+1,029
+7% +$22.9K ﹤0.01% 1198
2023
Q4 		$270K Buy
13,992
+2,641
+23% +$47.8K ﹤0.01% 1455
2023
Q3 		$183K Sell
11,351
-301
-3% -$5.34K ﹤0.01% 1499
2023
Q2 		$222K Buy
11,652
+886
+8% +$15.8K ﹤0.01% 1468
2023
Q1 		$157K Sell
10,766
-953
-8% -$17.1K ﹤0.01% 1506
2022
Q4 		$229K Buy
11,719
+1,508
+15% +$29.4K ﹤0.01% 1401
2022
Q3 		$246K Sell
10,211
-262
-3% -$8.07K ﹤0.01% 1262
2022
Q2 		$330K Sell
10,473
-5,772
-36% -$209K ﹤0.01% 1158
2022
Q1 		$716K Sell
16,245
-1,993
-11% -$85.6K ﹤0.01% 1071
2021
Q4 		$794K Buy
18,238
+6,953
+62% +$273K ﹤0.01% 1167
2021
Q3 		$353K Sell
11,285
-9,616
-46% -$378K ﹤0.01% 1422
2021
Q2 		$885K Sell
20,901
-715
-3% -$27.8K ﹤0.01% 1110
2021
Q1 		$813K Buy
21,616
+3,958
+22% +$124K ﹤0.01% 1115
2020
Q4 		$478K Buy
17,658
+8,638
+96% +$222K ﹤0.01% 1305
2020
Q3 		$226K Buy
+9,020
New +$132K ﹤0.01% 1351
2020
Q1 		– Sell
-10,263
Closed -$53K – 1458
2019
Q4 		$53K Buy
+10,263
New +$65.9K ﹤0.01% 1745
2019
Q1 		– Sell
-1,133,142
Closed -$7.17M – 1664
2018
Q4 		$7.17M Buy
1,133,142
+720,850
+175% +$7.48M 0.05% 336
2018
Q3 		$6.81M Buy
412,292
+7,513
+2% +$128K 0.05% 360
2018
Q2 		$6.76M Sell
404,779
-8,802
-2% -$142K 0.05% 350
2018
Q1 		$6.43M Sell
413,581
-353,330
-46% -$6.3M 0.04% 390
2017
Q4 		$14.5M Buy
766,911
+204,038
+36% +$4.52M 0.1% 170
2017
Q3 		$16.4M Buy
562,873
+63,332
+13% +$1.87M 0.15% 133
2017
Q2 		$16.1M Buy
499,541
+39,968
+9% +$1.31M 0.16% 123
2017
Q1 		$15.9M Buy
459,573
+81,587
+22% +$2.91M 0.17% 120
2016
Q4 		$13.3M Buy
377,986
+171,073
+83% +$5.78M 0.15% 125
2016
Q3 		$7.19M Buy
206,913
+85,622
+71% +$3M 0.1% 163
2016
Q2 		$4.53M Buy
121,291
+71,016
+141% +$2.67M 0.06% 264
2016
Q1 		$2.03M Buy
50,275
+13,585
+37% +$506K 0.03% 449
2015
Q4 		$1.32M Buy
36,690
+7,918
+28% +$286K 0.02% 643
2015
Q3 		$919K Sell
28,772
-986
-3% -$33.6K 0.01% 698
2015
Q2 		$1.01M Sell
29,758
-2,864
-9% -$96.5K 0.01% 770
2015
Q1 		$1.1M Buy
32,622
+1,373
+4% +$47.8K 0.01% 797
2014
Q4 		$1.1M Sell
31,249
-32,151
-51% -$1.08M 0.01% 809
2014
Q3 		$2.08M Sell
63,400
-2,015
-3% -$68.6K 0.03% 696
2014
Q2 		$2.22M Sell
65,415
-10,754
-14% -$368K 0.03% 673
2014
Q1 		$2.67M Buy
76,169
+24,260
+47% +$856K 0.03% 575
2013
Q4 		$1.9M Buy
51,909
+4,635
+10% +$170K 0.03% 758
2013
Q3 		$1.64M Buy
47,274
+1,186
+3% +$41.5K 0.04% 515
2013
Q2 		$1.56M Buy
+46,088
New +$1.53M 0.03% 586

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ProShare Advisors's ACH Position: Q2 2026 in Review

ProShare Advisors sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 10,931 shares — an estimated $24.9K sold.

ProShare Advisors first reported a position in ACH in Q2 2013 and held it in 47 quarters. The position peaked at $16.4M in Q3 2017. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • ProShare Advisors reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 10,931 Accendra Health shares in Q2 2026, an estimated $24.9K.
  • ProShare Advisors first reported a position in Accendra Health in Q2 2013 and held it in 47 quarters.
  • ProShare Advisors's Accendra Health position peaked at $16.4M in Q3 2017.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.